GlassScriptPhysician profile
Dan George Alexander
NPI 1053385955
$12,060.55
in general payments reported to CMS, 2019-2025
38 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $1,321 · 2021: $2,388 · 2022: $2,134 · 2023: $1,646 · 2024: $2,139 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,026 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,026.03 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,955.53 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $1,748.63 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Pfizer INC. | $1,210.13 | 2019-2025 | |
| Lilly USA, LLC | $1,206.76 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,143.54 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $800.47 | 2019-2025 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $774.63 | 2021-2025 | |
| Abbott Laboratories | $511.52 | 2021-2025 | Freestyle Libre 3, Ensite, Workmate Claris |
| Amarin Pharma, INC. | $280.93 | 2019-2022 | |
| Orexo US, INC. | $271.71 | 2019-2025 | Zubsolv |
| Indivior INC. | $270.77 | 2019-2024 | Sublocade |
| Gilead Sciences, INC. | $232.89 | 2022-2023 | |
| Esperion Therapeutics, INC. | $186.52 | 2020-2021 | |
| Exact Sciences Corporation | $163.78 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $144.93 | 2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.